2005 Update on Accelerated FDA Approval of Drugs Used To Treat Hematologic Malignancies from the Research on Adverse Drug-Events and Reports (RADAR): Rate of Regular Approval Conversion Remains Low.

Autor: Bennett, Charles L., Zagory, Jessica A. *, McKoy, June M., McCaffrey, Kathryn R. *, Lyons, E. Allison *, Belknap, Steven *
Zdroj: In Blood 16 November 2005 106(11):289-289
Databáze: ScienceDirect